Effect Size Analyses of Souvenaid in Patients with Alzheimer’s Disease

Background: Souvenaid(®) (uridine monophosphate, docosahexaenoic acid, eicosapentaenoic acid, choline, phospholipids, folic acid, vitamins B12, B6, C, and E, and selenium), was developed to support the formation and function of neuronal membranes. Objective: To determine effect sizes observed in cli...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Alzheimers Dis
Главные авторы: Cummings, Jeffrey, Scheltens, Philip, McKeith, Ian, Blesa, Rafael, Harrison, John E., Bertolucci, Paulo H.F., Rockwood, Kenneth, Wilkinson, David, Wijker, Wouter, Bennett, David A., Shah, Raj C.
Формат: Artigo
Язык:Inglês
Опубликовано: IOS Press 2016
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5147481/
https://ncbi.nlm.nih.gov/pubmed/27767993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-160745
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы